Influence of an interaction between lithium salts and a functional polymorphism in SLC1A2 on the history of illness in bipolar disorder. (Q48356710)

10 February 2018

title

Influence of an interaction between lithium salts and a functional polymorphism in SLC1A2 on the history of illness in bipolar disorder. (English)

1 reference

10 February 2018

1 reference

2

1 reference

10 February 2018

Francesco Benedetti

6

1 reference

10 February 2018

Sara Dallaspezia

Sara Dallaspezia

1

0 references

Adele Pirovano

Adele Pirovano

4

0 references

Cristina Lorenzi

Cristina Lorenzi

3

0 references

Cristina Colombo

Cristina Colombo

5

0 references

publication date

1 October 2012

1 reference

10 February 2018

Molecular Diagnosis and Therapy

published in

1 reference

10 February 2018

volume

16

1 reference

10 February 2018

issue

5

1 reference

10 February 2018

page(s)

303-309

1 reference

10 February 2018

https://scigraph.springernature.com/pub.10.1007/s40291-012-0004-5

exact match

0 references

cites work

Predicting the long-term outcome of affective disorders.

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Relapse and impairment in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Gender differences in a cohort study of 604 bipolar patients: the role of predominant polarity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-beta -50 T/C SNP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Mood-stabilizing drugs: mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Genomic organization of the human excitatory amino acid transporter gene GLT-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

A polymorphism in the EAAT2 promoter is associated with higher glutamate concentrations and higher frequency of progressing stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Association of an EAAT2 polymorphism with higher glutamate concentration in relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

The -181 A/C polymorphism in the excitatory amino acid transporter-2 gene promoter affects the personality trait of reward dependence in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Increased levels of glutamate in brains from patients with mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Case report: Successful riluzole augmentation therapy in treatment-resistant bipolar depression following the development of rash with lamotrigine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Ketamine and the next generation of antidepressants with a rapid onset of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Brain metabolic alterations in medication-free patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Spectroscopic correlates of antidepressant response to sleep deprivation and light therapy: a 3.0 Tesla study of bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Best estimate of lifetime psychiatric diagnosis: a methodological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Acute mania is accompanied by elevated glutamate/glutamine levels within the left dorsolateral prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Meta-analysis of magnetic resonance imaging brain morphometry studies in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Regional cerebral cortical thinning in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Depression: what we can learn from postmortem studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Excitatory amino acid transporters as potential drug targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Whole-genome association study of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

The role of hippocampal GluR1 and GluR2 receptors in manic-like behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Subgenual prefrontal cortex abnormalities in mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Lithium at 50: have the neuroprotective effects of this unique cation been overlooked?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Prefrontal gray matter increases in healthy individuals after lithium treatment: a voxel-based morphometry study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Voxelwise meta-analysis of gray matter abnormalities in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Opposite effects of suicidality and lithium on gray matter volumes in bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Glutamate-mediated calcium signaling: a potential target for lithium action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Lithium acts as a potentiator of AMPAR currents in hippocampal CA1 cells by selectively increasing channel open probability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Up-regulation of hippocampal glutamate transport during chronic treatment with sodium valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

Arachidonic acid inhibits a purified and reconstituted glutamate transporter directly from the water phase and not via the phospholipid membrane

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS40291-012-0004-5

21 January 2018

12 December 2020

Psychosis and relapse in bipolar disorder are related to GRM3, DAOA, and GRIN2B genotype.

1 reference

12 December 2020

Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.

1 reference

12 December 2020

RETRACTED: Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients

1 reference

12 December 2020

Course of illness and maintenance treatments for patients with bipolar disorder

1 reference

12 December 2020

Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: a longitudinal brain imaging study

1 reference

12 December 2020

Differential modulation of human glutamate transporter subtypes by arachidonic acid

1 reference

12 December 2020

The underlying neurobiology of bipolar disorder

1 reference

12 December 2020

Proton MR spectroscopy in children with bipolar affective disorder: preliminary observations

1 reference

12 December 2020

10.1007/S40291-012-0004-5

Identifiers

DOI

1 reference

10 February 2018

PubMed ID

23023733

1 reference

10 February 2018